Related Experiment Video
Updated: Jan 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Optimizing Lipid-Lowering Strategies Beyond Current Evidence
Mucahit Yetim1, Abdülmelik Birgün1, Macit Kalçık2
1Department of Cardiology, Faculty of Medicine, Hitit University, Buharaevler Mah. Buhara 25. Sok. No:1/A Daire:22, Corum, Turkey.
Moderate-intensity atorvastatin with ezetimibe showed non-inferiority to high-intensity atorvastatin for angina patients post-PCI. However, limitations in the study design necessitate further research for optimal lipid-lowering strategies.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Research
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for patients with angina.
- Lipid-lowering therapy is crucial for managing cardiovascular risk in these patients.
- Optimizing statin therapy, including combination approaches, remains an area of active investigation.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Bioavailability Enhancement: Drug Permeability Enhancement
Coronary Artery Disease IV: Preventive Measures
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements

